Zacks Research Equities Analysts Increase Earnings Estimates for Neogen Co. (NASDAQ:NEOG)

Neogen Co. (NASDAQ:NEOG - Free Report) - Equities research analysts at Zacks Research raised their Q3 2026 EPS estimates for shares of Neogen in a note issued to investors on Tuesday, April 30th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.17 per share for the quarter, up from their previous estimate of $0.16. The consensus estimate for Neogen's current full-year earnings is $0.46 per share. Zacks Research also issued estimates for Neogen's FY2026 earnings at $0.65 EPS.

Neogen (NASDAQ:NEOG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 9th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.02). Neogen had a net margin of 0.17% and a return on equity of 3.35%. The firm had revenue of $228.80 million for the quarter, compared to analyst estimates of $230.01 million. During the same quarter in the prior year, the firm earned $0.12 earnings per share. The firm's revenue for the quarter was up 4.8% on a year-over-year basis.

Separately, Piper Sandler dropped their target price on shares of Neogen from $19.00 to $17.00 and set a "neutral" rating for the company in a report on Monday, April 15th.

Neogen Price Performance

Shares of NEOG stock traded down $0.43 on Friday, hitting $12.02. 2,152,290 shares of the company's stock were exchanged, compared to its average volume of 2,162,726. The company has a 50 day moving average of $14.51 and a 200 day moving average of $16.24. The stock has a market cap of $2.60 billion, a P/E ratio of 1,216.22 and a beta of 1.18. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.82 and a quick ratio of 2.66. Neogen has a 12 month low of $11.46 and a 12 month high of $24.09.

Hedge Funds Weigh In On Neogen

A number of hedge funds have recently made changes to their positions in NEOG. Norges Bank acquired a new position in Neogen in the fourth quarter valued at $365,794,000. Baillie Gifford & Co. acquired a new position in shares of Neogen in the 4th quarter valued at about $166,646,000. Vanguard Group Inc. boosted its position in shares of Neogen by 9.3% during the 4th quarter. Vanguard Group Inc. now owns 19,546,737 shares of the company's stock valued at $393,085,000 after purchasing an additional 1,663,125 shares in the last quarter. Comerica Bank grew its stake in Neogen by 917.8% during the third quarter. Comerica Bank now owns 671,621 shares of the company's stock worth $12,452,000 after purchasing an additional 605,635 shares during the period. Finally, Trigran Investments Inc. bought a new stake in Neogen in the fourth quarter worth approximately $12,048,000. 96.73% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CFO David H. Naemura purchased 12,500 shares of Neogen stock in a transaction dated Wednesday, April 10th. The shares were bought at an average cost of $12.51 per share, for a total transaction of $156,375.00. Following the completion of the acquisition, the chief financial officer now owns 30,040 shares in the company, valued at approximately $375,800.40. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. In other Neogen news, CFO David H. Naemura purchased 12,500 shares of the business's stock in a transaction dated Wednesday, April 10th. The shares were bought at an average price of $12.51 per share, for a total transaction of $156,375.00. Following the completion of the acquisition, the chief financial officer now owns 30,040 shares in the company, valued at $375,800.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Douglas Edward Jones acquired 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, April 17th. The stock was bought at an average price of $12.36 per share, with a total value of $123,600.00. Following the completion of the acquisition, the chief operating officer now directly owns 46,131 shares of the company's stock, valued at $570,179.16. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 53,000 shares of company stock worth $662,205. Insiders own 0.71% of the company's stock.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.